Tirzepatide, a novel medication, is sparking significant buzz in the healthcare community as a viable treatment for both diabetes, type 2 and body composition . This dual-action drug works by stimulating two separate receptors, GLP-1 and GIP, leading to enhanced glucose control and notable fat loss in clinical trials . While preliminary findings ar